Atlas Trials

Non-Hodgkin Lymphoma (NHL)

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-Hodgkin Lymphoma (NHL)

RecordFirmDate
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors (NCT05225584)Kymera Therapeutics, Inc.2022-05-19
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) (NCT04702425)Novartis Pharmaceuticals2021-06-23
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies (NCT04186520)Medical College of Wisconsin2020-05-18
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels (NCT04537715)Epizyme, Inc.2020-04-23
Safety and Efficacy Evaluation of CD19-UCART (NCT03229876)Bioray Laboratories2019-06-01
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies (NCT03849651)St. Jude Children's Research Hospital2019-01-31
Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study (NCT03260101)Cellect Biotechnology2018-06-10
A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study (NCT02875548)Epizyme, Inc.2016-08-30
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation (NCT02790515)St. Jude Children's Research Hospital2016-07-14
Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (NCT02259348)St. Jude Children's Research Hospital2014-10-01
Study Evaluating Venetoclax in Subjects With Hematological Malignancies (NCT02265731)AbbVie2014-09-22
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy (NCT01829958)Memorial Sloan Kettering Cancer Center2013-04-01
Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab (NCT01707628)St. Antonius Hospital2012-10-01
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level (NCT01396070)Youn Kim2011-05-01
Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells (NCT01050764)Everett Meyer2009-06-01
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT (NCT01220297)Stanford University2006-08-01
Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL) (NCT03199066)Czech Lymphoma Study Group1999-01-01

Track Non-Hodgkin Lymphoma (NHL) automatically

Every clearance here is in the API, with alerts when new ones post.